282 related articles for article (PubMed ID: 34067494)
21. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
[TBL] [Abstract][Full Text] [Related]
22. Morphological characterization and subtyping of silent somatotroph adenomas.
Naritaka H; Kameya T; Sato Y; Furuhata S; Otani M; Kawase T
Pituitary; 1999 May; 1(3-4):233-41. PubMed ID: 11081203
[TBL] [Abstract][Full Text] [Related]
23. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
24. Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia.
Vidal S; Horvath E; Kovacs K; Lloyd RV; Smyth HS
Mod Pathol; 2001 Jan; 14(1):20-8. PubMed ID: 11211306
[TBL] [Abstract][Full Text] [Related]
25. Increased lactotrophs despite decreased somatotrophs in the dwarf (dw/dw) rat: a defect in the regulation of lactotroph/somatotroph cell fate?
Tierney T; Robinson IC
J Endocrinol; 2002 Nov; 175(2):435-46. PubMed ID: 12429041
[TBL] [Abstract][Full Text] [Related]
26. GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.
Srirangam Nadhamuni V; Iacovazzo D; Evanson J; Sahdev A; Trouillas J; McAndrew L; R Kurzawinski T; Bryant D; Hussain K; Bhattacharya S; Korbonits M
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34156350
[TBL] [Abstract][Full Text] [Related]
27. Silent somatotroph pituitary adenomas: an update.
Langlois F; Woltjer R; Cetas JS; Fleseriu M
Pituitary; 2018 Apr; 21(2):194-202. PubMed ID: 29305680
[TBL] [Abstract][Full Text] [Related]
28. A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx.
Peters J; Gryn O; Gerka-Stuyt J
Cureus; 2023 Sep; 15(9):e44985. PubMed ID: 37701167
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.
Rymuza J; Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Nyc A; Baluszek S; Zieliński G; Kunicki J; Bujko M
Cells; 2022 Nov; 11(23):. PubMed ID: 36497102
[TBL] [Abstract][Full Text] [Related]
30. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
[No Abstract] [Full Text] [Related]
31. The Pituitary in Gigantism.
Scheithauer BW; Kovacs KT; Stefaneanu L; Horvath E; Kane LA; Young WF; Lloyd RV; Randall RV; Davis DH
Endocr Pathol; 1995; 6(3):173-187. PubMed ID: 12114738
[TBL] [Abstract][Full Text] [Related]
32. Ectopic acromegaly due to a growth hormone-secreting neuroendocrine-differentiated tumor developed from ovarian mature cystic teratoma.
Ozkaya M; Sayiner ZA; Kiran G; Gul K; Erkutlu I; Elboga U
Wien Klin Wochenschr; 2015 Jun; 127(11-12):491-3. PubMed ID: 25869762
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of acromegaly.
Melmed S; Braunstein GD; Horvath E; Ezrin C; Kovacs K
Endocr Rev; 1983; 4(3):271-90. PubMed ID: 6354702
[TBL] [Abstract][Full Text] [Related]
34. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)].
Nagamine T; Fukuda I
No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068
[TBL] [Abstract][Full Text] [Related]
35. Pathologic Characteristics of Somatotroph Pituitary Tumors-An Observational Single-Center Study.
Tomasik A; Stelmachowska-Banaś M; Maksymowicz M; Czajka-Oraniec I; Raczkiewicz D; Zieliński G; Kunicki J; Zgliczyński W
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137536
[TBL] [Abstract][Full Text] [Related]
36. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
Kawakita S; Asa SL; Kovacs K
J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
[TBL] [Abstract][Full Text] [Related]
38. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA
J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385
[TBL] [Abstract][Full Text] [Related]
39. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
40. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
